Condition: Cancer · Sponsor: GRAIL, Inc.
This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek enrollment that is representative of the Medicare population.
This description comes directly from the study's public registry record.
GRAIL Medical Information · 833-694-2553 · customerservice@grail.com
Always discuss trial participation with your own doctor first.
| Mercy Health - Fort Smith | Fort Smith, Arkansas, United States | Recruiting |
| Sutter Valley Hospitals Auburn | Auburn, California, United States | Recruiting |
| Sutter Valley Hospitals Davis | Davis, California, United States | Recruiting |
| Sutter Valley Hospitals Elk Grove | Elk Grove, California, United States | Recruiting |
| Long Beach Memorial Orange Coast | Fountain Valley, California, United States | Recruiting |
| Long Beach Memorial Saddleback | Laguna Hills, California, United States | Recruiting |
| Long Beach Memorial Atlantic | Long Beach, California, United States | Recruiting |
| Sutter Valley Hospitals Modesto | Modesto, California, United States | Recruiting |
| Sutter Valley Hospitals PAMF Sutter | Palo Alto, California, United States | Recruiting |
| Sutter Valley Hospitals Roseville | Roseville, California, United States | Recruiting |
| Sutter Valley Hospitals Alhambra | Sacramento, California, United States | Recruiting |
| Sutter Valley Hospitals Capitol Pavilion | Sacramento, California, United States | Recruiting |
+ 49 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05673018